Angus Grant, PhD

Observer
DISC Type : ci

Managing Partner at AJG Biopharma Advisors

United States

Overview

Angus Grant is a seasoned biopharma executive with over 25 years of experience in business development, corporate strategy, M&A, and R&D. As EVP of Business Development at Teva Pharmaceuticals, he leads strategic partnerships to bring innovative medicines to patients. He holds a Ph. D. in anatomy and immunology from Virginia Commonwealth University School of Medicine.

In his spare time, Angus can be found in or on the Connecticut River or Long Island Sound. His previous role as CEO of the Dementia Discovery Fund was motivated by a personal commitment to help the millions of people suffering from neurodegenerative diseases.

He is a published scientist who has co-authored more than 15 articles in peer-reviewed scientific journals.

Personality Overview

Value Driven

Curious

Assertive

They are generally good communicators and can be hard to convince.  They can sound friendly and charming but can quickly change gears to become inquisitive and probing. They are likely to ask many questions and look heavily for supporting information.

Topics They Care About

Biopharma Dealmaking
He has led business development for multiple major pharmaceutical companies, executing deals for R&D, licensing, and large-scale M&A, including a $9 billion acquisition.
Dementia Research
Served as CEO of the Dementia Discovery Fund, the world's largest venture fund focused solely on developing novel therapies for dementia and other neurodegenerative diseases.
Passion-driven Collaboration
Believes a successful partnership is based on whether the teams "share a common passion" and enjoy working together, a philosophy he has learned over his long career.

Media Appearances

Angus has no verified media appearances

Work History

12-2025
Managing Partner at AJG Biopharma Advisors
8-2023 - 1-2025
Executive Vice President, Business Development, Teva at Teva Pharmaceuticals
7-2020 - 6-2023
Chief Business Executive, SVP at BeiGene
9-2019
Chair Of The Board Of Directors at TIAP - Toronto Innovation Acceleration Partners
7-2018 - 6-2020
CEO at Dementia Discovery Fund

Education

1983 - 1988
PhD from Virginia Commonwealth University School of Medicine
1978 - 1983
BA from University of Richmond

More Information

Social Presence :

Prographics :

Exp : 33 Location : United States Job Level : N/A Designation : Managing Partner at AJG Biopharma Advisors
URL has been copied!

Insights For Selling To Angus

During A Call Or A Meeting

DO's

  • Be prepared for a lot of questions, answer them objectively
  • Help them realize that there is no personal risk in making this decision
  • Focus on immediate action-items rather than the larger goals

DONT's

  • Avoid making offhand commitments
  • Don’t try to rush them into a decision, provide all necessary information first
  • Don’t rely excessively on your relationship with them to win the deal

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Angus is

  • Proven value, strong testimonials are important to them, relationships will have some weightage.
  • Will you ever get a clear answer from Angus

  • They are practical and friendly, don't expect a clear-cut response often.

Insights For Deal Planning

    How fast (or slow) will Angus move?

  • They like to perform full analysis and can take time to make any decision.
  • Can Angus take some risk or not?

  • They evaluate their decisions systematically and are less likely to take risks.

You And Angus

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.